Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

EHF

ets homologous factor


Gene EHF gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Anti-Ulcer Agents/therapeutic use

216.0

English Abstract

460.0

Humans

1060.0

Animals

260.0

Immunoglobulin E/blood

21.0

Infant

100.0

Research Support, Non-U.S. Gov't

210.0

Adult

500.0

*Disease Outbreaks

1017.0

Female

500.0

Male

530.0

Uganda/epidemiology

416.0

Acute Disease

20.0

Microwaves/*therapeutic use

750.0

Incidence

30.0

Population Surveillance

21.0

Risk Factors

60.0

Seasons

21.0

Time Factors

110.0

Antibodies, Viral/blood

65.0

Hantaan virus/*immunology

375.0

Hemorrhagic Fever with Renal Syndrome/*prevention & control

3100.0

Gerbillinae

25.0

Mice

110.0

Case-Control Studies

20.0

China/epidemiology

63.0

*Disease Reservoirs

832.0

Hantaan virus/immunology/*isolation & purification

2100.0

Cohort Studies

110.0

Comparative Study

110.0

Hydrolysis

20.0

Immunoglobulin G/blood

31.0

Leukocytes, Mononuclear/immunology

20.0

Milk/*immunology

233.0

Chronic Disease

40.0

Middle Aged

340.0

Treatment Outcome

30.0

Africa/epidemiology

28.0

Adolescent

260.0

Severity of Illness Index

30.0

*Infant Food

25.0

Prospective Studies

80.0

Aged

120.0

Prognosis

40.0

Child

120.0

Otitis Media/*complications

2100.0

Recurrence

30.0

Research Support, U.S. Gov't, P.H.S.

50.0

Sensitivity and Specificity

30.0

Disease Outbreaks

35.0

Acupuncture Points

350.0

Antibody Formation/drug effects/radiation effects

2100.0

Drug Therapy, Combination

20.0

Immunity, Cellular/drug effects/radiation effects

266.0

Amino Acid Sequence

20.0

Base Sequence

20.0

*Chromosomes, Human, Pair 11

20.0

Molecular Sequence Data

20.0

Tissue Distribution

20.0

Age Factors

40.0

Risk Assessment

20.0

*Disability Evaluation

220.0

Retrospective Studies

50.0

*Severity of Illness Index

23.0

World Health Organization

56.0

Infant, Newborn

40.0

Postoperative Complications

21.0

Animals, Newborn

20.0

Antigens, Viral/metabolism

418.0

Swine

20.0

Democratic Republic of the Congo/epidemiology

990.0

Enzyme-Linked Immunosorbent Assay

20.0

Immunoglobulin M/blood

21.0

Rabbits

20.0

Health Personnel

211.0

Hemorrhagic Fever, Ebola/*epidemiology/*immunology/transmission

2100.0

Patient Isolation

250.0

Contact Tracing

233.0

Epidemiologic Factors

350.0

Body Fluids/virology

266.0

Housing

215.0

Child, Preschool

40.0

Microscopy, Electron

40.0

Microwaves/therapeutic use

2100.0

Remission Induction

30.0

Mice, Inbred BALB C

20.0

Hemodynamic Processes

21.0

Environment

33.0

Adsorption

21.0

Combined Modality Therapy

40.0

Biopsy

20.0

Immunohistochemistry

30.0

In Situ Hybridization

20.0

RNA, Viral/analysis

20.0

Epithelium/virology

225.0

Hemorrhagic Fever with Renal Syndrome/*pathology/*virology

2100.0

Rats

50.0

*Electromagnetic Fields

517.0

Evaluation Studies

20.0

Hypothalamo-Hypophyseal System/*physiopathology

23.0

Pituitary-Adrenal System/*physiopathology

28.0

Antigens, Viral/*analysis

36.0

Hantavirus/*isolation & purification

2100.0

Hemorrhagic Fever with Renal Syndrome/*diagnosis

2100.0

Hemagglutination Inhibition Tests

36.0

Muridae/*microbiology

2100.0

Rats/*microbiology

3100.0

Serotyping

62.0

Reproducibility of Results

20.0

Hemorrhagic Fever with Renal Syndrome/*transmission

2100.0

Mites/*microbiology

2100.0

Hantavirus/*classification

266.0

Muridae/microbiology

4100.0

Rosette Formation

20.0

Hantavirus/*immunology

480.0

Hemorrhagic Fever with Renal Syndrome/*epidemiology

5100.0

*Viral Vaccines

212.0

Hemorrhagic Fever with Renal Syndrome/*immunology

240.0

Antibodies, Viral/analysis

43.0

China

51.0

Hantavirus/immunology

375.0

Carrier State/*epidemiology

250.0

Syndrome

20.0

Cells, Cultured

20.0

Radiation Dosage

22.0